#1 Clinical Trials Search in Europe

Oxitriptan

Oxitriptan, also known as 5-hydroxytryptophan (5-HTP), is a naturally occurring amino acid and chemical precursor of serotonin. This article examines recent clinical trials investigating the potential therapeutic uses of 5-HTP for various conditions, including depression, anxiety, asthma, and obesity. Researchers are exploring how 5-HTP supplementation may help regulate mood, appetite, and other bodily functions by increasing serotonin levels in the brain.

Table of Contents

What is OXITRIPTAN?

OXITRIPTAN, also known as 5-hydroxytryptophan (5-HTP), is a naturally occurring amino acid produced by the human body from the essential amino acid L-tryptophan, which is found in food products[1]. It is also available as a dietary supplement derived from the seeds of Griffonia simplicifolia, a West African medicinal plant[1]. 5-HTP has been used clinically for more than 30 years and is available as an over-the-counter supplement in some countries, including the United States and Italy[2].

How OXITRIPTAN Works

OXITRIPTAN (5-HTP) is the immediate precursor to serotonin, an important neurotransmitter in the brain. When taken as a supplement, 5-HTP can cross the blood-brain barrier and increase serotonin production[1]. Serotonin plays a crucial role in regulating mood, appetite, and sleep patterns. By increasing serotonin levels, 5-HTP may help improve various conditions related to serotonin deficiency[2].

Medical Conditions Treated with OXITRIPTAN

OXITRIPTAN (5-HTP) has been investigated for several medical conditions, including:

  • Major Depressive Disorder (MDD): 5-HTP is being studied as a potential treatment for depression, especially in cases where standard antidepressants (SSRIs or SNRIs) have not been effective[3][4].
  • Anxiety: Some research suggests that 5-HTP may help reduce symptoms of anxiety[1].
  • Obesity and Weight Management: 5-HTP has been studied for its potential to reduce appetite and food intake, which could aid in weight loss efforts[2].
  • Asthma: Researchers are investigating whether 5-HTP can improve breathing and anxiety symptoms related to asthma[5].
  • Fragile X Syndrome: 5-HTP is being studied in combination with other supplements to potentially improve symptoms associated with this genetic condition[1].
  • Spinal Cord Injuries: Some research is exploring the effects of 5-HTP on nervous system excitability and motor function in individuals with spinal cord injuries[6].

Dosage and Administration

The dosage of OXITRIPTAN (5-HTP) can vary depending on the condition being treated and the individual’s body weight. In clinical trials, the following dosages have been used:

  • For depression: 100-200 mg taken twice daily[3].
  • For weight management: 50-150 mg taken before meals[2].
  • For asthma in children: 50-100 mg taken twice daily, depending on body weight[5].

It’s important to note that these dosages are based on research studies and may not be appropriate for everyone. Always consult with a healthcare professional before starting any new supplement regimen.

Potential Benefits

Research suggests that OXITRIPTAN (5-HTP) may offer several potential benefits:

  • Improved mood and reduced depressive symptoms: By increasing serotonin levels, 5-HTP may help alleviate symptoms of depression[3].
  • Increased satiety and reduced food intake: Some studies have shown that 5-HTP may help reduce appetite and calorie consumption, which could be beneficial for weight management[2].
  • Improved lung function in asthma patients: Ongoing research is investigating whether 5-HTP can help improve breathing in individuals with asthma[5].
  • Enhanced nervous system function: Studies are exploring the potential of 5-HTP to improve motor function and nervous system excitability in individuals with spinal cord injuries[6].

Side Effects and Safety

While OXITRIPTAN (5-HTP) is generally considered safe when taken as directed, it may cause some side effects. Common side effects reported in clinical trials include:

  • Nausea
  • Digestive discomfort
  • Headache
  • Drowsiness

To minimize the risk of side effects, some studies have combined 5-HTP with other substances. For example, in a study on depression, 5-HTP was administered with carbidopa to reduce peripheral side effects such as nausea[6].

It’s important to note that 5-HTP may interact with certain medications, particularly those that affect serotonin levels, such as antidepressants. Always consult with a healthcare provider before starting 5-HTP, especially if you are taking other medications or have pre-existing health conditions.

Ongoing Research

Several clinical trials are currently underway to further investigate the potential benefits and applications of OXITRIPTAN (5-HTP):

  • A study is examining the combination of 5-HTP and creatine for treatment-resistant depression, particularly in individuals living at high altitudes where chronic hypoxia (low oxygen levels) may contribute to depression[4].
  • Researchers are investigating the effects of 5-HTP on asthma symptoms in children, including its potential to improve lung function and reduce anxiety[5].
  • A trial is exploring the use of 5-HTP in combination with ergoloid mesylates for improving symptoms in adults with Fragile X Syndrome[1].
  • Scientists are studying how 5-HTP affects nervous system function and motor abilities in individuals with spinal cord injuries[6].

These ongoing studies aim to provide more comprehensive data on the efficacy, safety, and optimal dosing of OXITRIPTAN (5-HTP) for various medical conditions.

Condition Study Design Dosage Duration Primary Outcome Measures
Major Depressive Disorder Randomized, double-blind, placebo-controlled 100mg or 200mg BID with creatine 8 weeks Change in Hamilton Depression Rating Scale
Spinal Cord Injuries Randomized, double-blind, placebo-controlled crossover 50mg or 100mg with carbidopa 4 treatment periods of 4 weeks each Change in motoneuron excitability
Fragile X Syndrome Single-blind, 4-period sequential 100mg TID 4 weeks per treatment period Safety and tolerability, adverse events
Asthma Randomized, double-blind, placebo-controlled crossover 50mg or 100mg BID based on weight 28 days per treatment period Change in FEV1
Obesity Randomized, placebo-controlled 100mg daily 1 week Satiety scores (visual analog scales)

FAQ

  • What is Oxitriptan (5-HTP)? Oxitriptan, also known as 5-hydroxytryptophan (5-HTP), is an amino acid that occurs naturally in the body. It is a precursor to serotonin, an important neurotransmitter involved in regulating mood, sleep, appetite, and pain sensation.
  • What conditions are being studied with 5-HTP in clinical trials? Clinical trials are investigating the potential benefits of 5-HTP for various conditions, including major depressive disorder, anxiety, asthma, obesity, spinal cord injuries, and Fragile X Syndrome.
  • How is 5-HTP typically administered in these trials? In the clinical trials reviewed, 5-HTP is usually administered orally in capsule form. Dosages vary depending on the study, but common doses range from 50 mg to 200 mg taken once to three times daily.
  • Are there any side effects associated with 5-HTP supplementation? While 5-HTP is generally considered safe, some studies monitor for potential side effects such as nausea, changes in mood, and changes in appetite. Long-term safety and efficacy are still being evaluated in ongoing clinical trials.
  • How long do the clinical trials involving 5-HTP typically last? The duration of 5-HTP clinical trials varies widely depending on the study design and objectives. Some trials last for a few weeks, while others may continue for several months to assess long-term effects and safety.

Ongoing Clinical Trials on Oxitriptan

  • Study on the Safety and Effectiveness of Oxitriptan and Tamsulosin Hydrochloride for Patients with Benign Prostatic Hyperplasia

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal

Glossary

  • 5-hydroxytryptophan (5-HTP): An amino acid that is a precursor to serotonin, naturally produced in the body from the essential amino acid L-tryptophan. It is also available as a dietary supplement.
  • Serotonin: A neurotransmitter that plays a crucial role in regulating mood, anxiety, happiness, and other important functions in the body.
  • Major Depressive Disorder (MDD): A mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in activities, lasting for at least two weeks and interfering with daily life.
  • Fragile X Syndrome (FXS): A genetic disorder causing intellectual disability, behavioral and learning challenges, and various physical characteristics. It is the most common known single-gene cause of autism spectrum disorder.
  • Creatine Monohydrate: A supplement often used in combination with 5-HTP in some studies, known for its potential to improve brain bioenergetics and mood.
  • Hamilton Depression Rating Scale (HAM-D): A multiple-item questionnaire used to provide an indication of depression and as a guide to evaluate recovery. Scores range from 0 to 52, with higher scores indicating more severe depression.
  • Forced Expiratory Volume in 1 second (FEV1): A measure of lung function used in assessing conditions like asthma. It represents the volume of air that can be forcibly exhaled in one second after taking a deep breath.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare with the effects of the active drug or treatment being studied.
  • Double-blind study: A research design in which neither the participants nor the researchers directly involved know who is receiving the experimental treatment and who is receiving a placebo or standard treatment.
  • Crossover design: A type of clinical trial where participants receive two or more treatments in a specific order, allowing each participant to serve as their own control.

References

  1. https://clinicaltrials.gov/study/NCT05030129
  2. https://clinicaltrials.gov/study/NCT00328913
  3. https://clinicaltrials.gov/study/NCT05895747
  4. https://clinicaltrials.gov/study/NCT02356107
  5. https://clinicaltrials.gov/study/NCT04160910
  6. https://clinicaltrials.gov/study/NCT04520178